Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ina Monsef

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
The Cochrane Database of Systematic Reviews|February 17, 2016
Granulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromesFranz Hutzschenreuter, Ina Monsef, Karl-Anton Kreuzer, et al.
The Cochrane Database of Systematic Reviews|February 1, 2019
Aerobic physical exercise for adult patients with haematological malignanciesLinus Knips, Nils Bergenthal, Fiona Streckmann, et al.
Journal of the National Cancer Institute|July 16, 2013
Fifteenth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin's lymphomaMichaela Rancea, Andrea Will, Peter Borchmann, et al.
Journal of the National Cancer Institute|July 18, 2014
Sixteenth biannual report of the Cochrane Haematological Malignancies Group: focus on Non-Hodgkin's lymphomaMichaela Rancea, Andrea Will, Peter Borchmann, et al.
The Cochrane Database of Systematic Reviews|August 7, 2018
Effects of all-trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non-acute promyelocytic leukaemia (non-APL))Yasemin Küley-Bagheri, Karl-Anton Kreuzer, Ina Monsef, et al.
The Cochrane Database of Systematic Reviews|May 2, 2024
Daratumumab and antineoplastic therapy versus antineoplastic therapy only for adults with newly diagnosed multiple myeloma ineligible for transplantPeter Langer, Lukas John, Ina Monsef, et al.
The Cochrane Database of Systematic Reviews|December 22, 2015
Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapyNicole Skoetz, Julia Bohlius, Andreas Engert, et al.
The Cochrane Database of Systematic Reviews|May 26, 2017
Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphomaNicole Skoetz, Andrea Will, Ina Monsef, et al.
The Cochrane Database of Systematic Reviews|April 28, 2017
Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphomaOliver Blank, Bastian von Tresckow, Ina Monsef, et al.
The Cochrane Database of Systematic Reviews|February 17, 2012
Alemtuzumab for patients with chronic lymphocytic leukaemiaNicole Skoetz, Kathrin Bauer, Thomas Elter, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
The Cochrane Database of Systematic Reviews|February 17, 2016
Granulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromesFranz Hutzschenreuter, Ina Monsef, Karl-Anton Kreuzer, et al.
The Cochrane Database of Systematic Reviews|February 1, 2019
Aerobic physical exercise for adult patients with haematological malignanciesLinus Knips, Nils Bergenthal, Fiona Streckmann, et al.
Journal of the National Cancer Institute|July 16, 2013
Fifteenth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin's lymphomaMichaela Rancea, Andrea Will, Peter Borchmann, et al.
Journal of the National Cancer Institute|July 18, 2014
Sixteenth biannual report of the Cochrane Haematological Malignancies Group: focus on Non-Hodgkin's lymphomaMichaela Rancea, Andrea Will, Peter Borchmann, et al.
The Cochrane Database of Systematic Reviews|August 7, 2018
Effects of all-trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non-acute promyelocytic leukaemia (non-APL))Yasemin Küley-Bagheri, Karl-Anton Kreuzer, Ina Monsef, et al.
The Cochrane Database of Systematic Reviews|May 2, 2024
Daratumumab and antineoplastic therapy versus antineoplastic therapy only for adults with newly diagnosed multiple myeloma ineligible for transplantPeter Langer, Lukas John, Ina Monsef, et al.
The Cochrane Database of Systematic Reviews|December 22, 2015
Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapyNicole Skoetz, Julia Bohlius, Andreas Engert, et al.
The Cochrane Database of Systematic Reviews|May 26, 2017
Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphomaNicole Skoetz, Andrea Will, Ina Monsef, et al.
The Cochrane Database of Systematic Reviews|April 28, 2017
Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphomaOliver Blank, Bastian von Tresckow, Ina Monsef, et al.
The Cochrane Database of Systematic Reviews|February 17, 2012
Alemtuzumab for patients with chronic lymphocytic leukaemiaNicole Skoetz, Kathrin Bauer, Thomas Elter, et al.
Pageof 9